More than 150,000 licensed drivers have left the profession in recent years because of these zero-tolerance workplace drug testing policies.
Author: Paul Armentano, NORML Deputy Director
April 20 is the most widely celebrated day in cannabis culture. This 4/20, we have plenty to celebrate.
After a century of failed policies and “canna-bigotry,” the verdict is in. Legalization is a success, and the end of cannabis prohibition can’t come soon enough.
Lawmakers are increasingly hearing from business interests, not from consumers and grassroots advocates. That is why it is more important than ever that NORML maintains a seat at the table to ensure that consumers’ interests are heard and taken seriously.
Federal health officials concluded, “The risks to the public health posed by marijuana are low compared to other drugs of abuse,” such as benzodiazepines — a Schedule IV drug, or alcohol, which is unscheduled.
Prohibiting adults from accessing these products from state-licensed retailers will not eliminate consumers’ demand for them. Rather, it will encourage consumers to seek out higher-THC products in the unregulated market.
In a healthy and functioning democracy, elected officials represent the views of the electorate. But, when it comes to the issue of cannabis law reform, Republican lawmakers all too often ignore or seek to undermine their voters.
Numerous studies assessing the long-term health impacts of cannabis smoke exposure belie the myth that marijuana is associated with the same sort of well established, adverse respiratory hazards as tobacco.